Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexa S Green

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Blood|January 27, 2018
A pernicious mean corpuscular volumeAlexa S Green, Nicolas Chapuis
Cell Cycle (Georgetown, Tex.)|May 17, 2011
LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biologyAlexa S Green, Nicolas Chapuis, Catherine Lacombe, et al.
Blood|February 21, 2012
The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cellsMarie-Anne Hospital, Alexa S Green, Catherine Lacombe, et al.
Cell Cycle (Georgetown, Tex.)|November 26, 2009
Targeting translation in acute myeloid leukemia: a new paradigm for therapy?Jerome Tamburini, Alexa S Green, Nicolas Chapuis, et al.
Oncotargets and Therapy|February 23, 2017
FLT3 inhibitors: clinical potential in acute myeloid leukemiaMarie-Anne Hospital, Alexa S Green, Thiago T Maciel, et al.
Blood|May 22, 2009
Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemiaJerome Tamburini, Alexa S Green, Valerie Bardet, et al.
Cytometry. Part B, Clinical Cytometry|September 10, 2019
Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1-tube panel strategy for diagnosis and prognosis of patients with MDSSylvain Barreau, Alexa S Green, Charles Dussiau, et al.
Haematologica|December 17, 2009
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibodyNicolas Chapuis, Jérôme Tamburini, Pascale Cornillet-Lefebvre, et al.
British Journal of Haematology|October 15, 2011
The eukaryotic initiating factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemiaAlexa S Green, Sophie Grabar, Micheline Tulliez, et al.
Blood|July 31, 2010
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemiaNicolas Chapuis, Sophie Park, Laurent Leotoing, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Blood|January 27, 2018
A pernicious mean corpuscular volumeAlexa S Green, Nicolas Chapuis
Cell Cycle (Georgetown, Tex.)|May 17, 2011
LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biologyAlexa S Green, Nicolas Chapuis, Catherine Lacombe, et al.
Blood|February 21, 2012
The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cellsMarie-Anne Hospital, Alexa S Green, Catherine Lacombe, et al.
Cell Cycle (Georgetown, Tex.)|November 26, 2009
Targeting translation in acute myeloid leukemia: a new paradigm for therapy?Jerome Tamburini, Alexa S Green, Nicolas Chapuis, et al.
Oncotargets and Therapy|February 23, 2017
FLT3 inhibitors: clinical potential in acute myeloid leukemiaMarie-Anne Hospital, Alexa S Green, Thiago T Maciel, et al.
Blood|May 22, 2009
Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemiaJerome Tamburini, Alexa S Green, Valerie Bardet, et al.
Cytometry. Part B, Clinical Cytometry|September 10, 2019
Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1-tube panel strategy for diagnosis and prognosis of patients with MDSSylvain Barreau, Alexa S Green, Charles Dussiau, et al.
Haematologica|December 17, 2009
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibodyNicolas Chapuis, Jérôme Tamburini, Pascale Cornillet-Lefebvre, et al.
British Journal of Haematology|October 15, 2011
The eukaryotic initiating factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemiaAlexa S Green, Sophie Grabar, Micheline Tulliez, et al.
Blood|July 31, 2010
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemiaNicolas Chapuis, Sophie Park, Laurent Leotoing, et al.
Pageof 2